<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Anixa Biosciences and Cleveland Clinic Receive FDA Clearance for Clinical Trials of Breast Cancer Vaccine
Image Overlay - Anixa Biosciences and Cleveland Clinic Receive FDA Clearance for Clinical Trials of Breast Cancer Vaccine

Anixa Biosciences and Cleveland Clinic Receive FDA Clearance for Clinical Trials of Breast Cancer Vaccine

Anixa Biosciences and Cleveland Clinic Receive FDA Clearance for Clinical Trials of Breast Cancer Vaccine

Anixa Biosciences announced that the FDA has cleared the Investigational New Drug (IND) application for its breast cancer vaccine. The technology immunizes against the alpha-lactalbumin protein that is expressed in the mammary glands of women during lactation. After lactation, the protein is no longer expressed until a woman develops breast cancer. Researchers anticipate that the vaccine will support the immune system in destroying cancer cells before they have the opportunity to grow into a mature cancer. Yourway is looking forward to seeing the results of further trials and fully supports the fight against cancer.

Back to Index
Media

Upcoming Events

Precision in Pharma Supply Chain & Logistics Summit (Munich)

April 15-16, 2024
Science Congress Center Munich

GCSG 2024 US Conference

April 21-24, 2024
Naples, Florida

Media

Articles

The At-home Trial Experience: Leveraging value-chain to reach and retain patients

Open chat
Come chat with us!
Hello! How can I help you?